| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Greenberg Arthur is a Director at GALT. Recent filings cover 1 purchase and 0 sales. Those positions are worth an estimated $378K at current prices.
Greenberg Arthur's largest disclosed position is in GALT as Director, worth about $378K. Net of sales, the recent Form 4 record there shows accumulation of 1,666 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 5, 2016 | GALT Galectin Therapeutics Inc | Director | Buy | 1,666 | $1.72 | $2,865.52 | +1.5% |